According to a report from Radio Prague International, the Czech Ministry of Health is developing regulations to classify nicotine pouches as tobacco products for regulation purposes.
Currently, nicotine pouches are not regulated in the Czech Republic. "We are aware of the issues that this is causing," said Ondřej Jakob, spokesperson for the Ministry of Health. "We are in the process of developing legislation to determine the properties, labeling, and regulation of this product. We are also studying amendments to existing laws.
According to Jakob, the new regulation may come into effect in a few months.
Health activists are expressing concerns over the growing popularity of nicotine pouches in the Czech Republic, particularly among young people. Marek Lžičař, an addiction expert at St. Anne's Hospital in Brno, has stated that children can develop addictions to these products in just a few weeks.
He stated, "The risk of addiction is significant for anyone, whether they are children or adults, and should not be downplayed. This is a risky behavior that could potentially lead to the use of other tobacco products. It could also lead to the use of softer or harder drugs.
Experts believe that the increasing use of addictive substances among children is due to the prolonged social isolation caused by the Covid-19 pandemic.
Source: Tobacco Reporter
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
